Juan Sanabria
Stock Analyst at BMO Capital
(1.34)
# 3,333
Out of 4,842 analysts
91
Total ratings
41.38%
Success rate
-4.31%
Average return
Main Sectors:
Stocks Rated by Juan Sanabria
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ELS Equity LifeStyle Properties | Maintains: Outperform | $78 → $77 | $62.60 | +23.00% | 2 | Apr 22, 2025 | |
SKT Tanger | Initiates: Market Perform | $36 | $29.78 | +20.89% | 1 | Jan 28, 2025 | |
CTRE CareTrust REIT | Downgrades: Market Perform | $34 → $32 | $28.39 | +12.72% | 3 | Dec 9, 2024 | |
OHI Omega Healthcare Investors | Upgrades: Outperform | $45 | $36.36 | +23.76% | 3 | Dec 9, 2024 | |
BRX Brixmor Property Group | Upgrades: Outperform | $30 → $33 | $25.54 | +29.23% | 2 | Dec 6, 2024 | |
CUBE CubeSmart | Downgrades: Market Perform | $50 → $47 | $42.41 | +10.82% | 11 | May 29, 2024 | |
PSA Public Storage | Maintains: Outperform | $325 → $330 | $304.70 | +8.30% | 3 | Mar 19, 2024 | |
NHI National Health Investors | Upgrades: Outperform | $67 | $72.45 | -7.52% | 1 | Mar 12, 2024 | |
PECO Phillips Edison & Company | Maintains: Market Perform | $37 → $40 | $35.27 | +13.41% | 2 | Dec 15, 2023 | |
HR Healthcare Realty Trust | Maintains: Market Perform | $20 → $17 | $14.44 | +17.73% | 1 | Oct 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $38 | $35.15 | +8.11% | 5 | Dec 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $45 | $33.08 | +36.03% | 1 | Apr 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $46 | $37.25 | +23.49% | 1 | Apr 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $70 → $75 | $33.75 | +122.22% | 3 | Dec 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $80 → $82 | $72.03 | +13.84% | 1 | Dec 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $145 | $95.73 | +51.47% | 1 | Dec 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $100 | $152.26 | -34.32% | 3 | Aug 26, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | $60 | $64.01 | -6.26% | 4 | Aug 26, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $20 → $21 | $17.31 | +21.35% | 8 | May 21, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $160 | $149.98 | +6.68% | 7 | May 14, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $6.30 | +154.17% | 1 | Apr 16, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $120 → $125 | $162.65 | -23.15% | 1 | Apr 15, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $266 → $273 | $279.79 | -2.43% | 5 | Nov 16, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $7.96 | - | 3 | May 18, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $438.60 | - | 6 | Mar 1, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $42 | $40.96 | +2.54% | 4 | Jun 8, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $197 → $198 | $203.87 | -2.88% | 4 | Jun 8, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $103 → $104 | $116.21 | -10.51% | 1 | Jun 8, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $74 → $76 | $69.40 | +9.51% | 2 | Jun 8, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $17.37 | +3.66% | 1 | Mar 8, 2018 |
Equity LifeStyle Properties
Apr 22, 2025
Maintains: Outperform
Price Target: $78 → $77
Current: $62.60
Upside: +23.00%
Tanger
Jan 28, 2025
Initiates: Market Perform
Price Target: $36
Current: $29.78
Upside: +20.89%
CareTrust REIT
Dec 9, 2024
Downgrades: Market Perform
Price Target: $34 → $32
Current: $28.39
Upside: +12.72%
Omega Healthcare Investors
Dec 9, 2024
Upgrades: Outperform
Price Target: $45
Current: $36.36
Upside: +23.76%
Brixmor Property Group
Dec 6, 2024
Upgrades: Outperform
Price Target: $30 → $33
Current: $25.54
Upside: +29.23%
CubeSmart
May 29, 2024
Downgrades: Market Perform
Price Target: $50 → $47
Current: $42.41
Upside: +10.82%
Public Storage
Mar 19, 2024
Maintains: Outperform
Price Target: $325 → $330
Current: $304.70
Upside: +8.30%
National Health Investors
Mar 12, 2024
Upgrades: Outperform
Price Target: $67
Current: $72.45
Upside: -7.52%
Phillips Edison & Company
Dec 15, 2023
Maintains: Market Perform
Price Target: $37 → $40
Current: $35.27
Upside: +13.41%
Healthcare Realty Trust
Oct 6, 2023
Maintains: Market Perform
Price Target: $20 → $17
Current: $14.44
Upside: +17.73%
Dec 16, 2022
Downgrades: Underperform
Price Target: $38
Current: $35.15
Upside: +8.11%
Apr 14, 2022
Initiates: Market Perform
Price Target: $45
Current: $33.08
Upside: +36.03%
Apr 14, 2022
Initiates: Outperform
Price Target: $46
Current: $37.25
Upside: +23.49%
Dec 13, 2021
Upgrades: Outperform
Price Target: $70 → $75
Current: $33.75
Upside: +122.22%
Dec 1, 2021
Upgrades: Outperform
Price Target: $80 → $82
Current: $72.03
Upside: +13.84%
Dec 1, 2021
Upgrades: Outperform
Price Target: $145
Current: $95.73
Upside: +51.47%
Aug 26, 2021
Upgrades: Outperform
Price Target: $100
Current: $152.26
Upside: -34.32%
Aug 26, 2021
Upgrades: Market Perform
Price Target: $60
Current: $64.01
Upside: -6.26%
May 21, 2021
Upgrades: Outperform
Price Target: $20 → $21
Current: $17.31
Upside: +21.35%
May 14, 2021
Downgrades: Market Perform
Price Target: $160
Current: $149.98
Upside: +6.68%
Apr 16, 2021
Initiates: Outperform
Price Target: $16
Current: $6.30
Upside: +154.17%
Apr 15, 2021
Maintains: Market Perform
Price Target: $120 → $125
Current: $162.65
Upside: -23.15%
Nov 16, 2020
Maintains: Buy
Price Target: $266 → $273
Current: $279.79
Upside: -2.43%
May 18, 2020
Downgrades: Underperform
Price Target: n/a
Current: $7.96
Upside: -
Mar 1, 2019
Downgrades: Neutral
Price Target: n/a
Current: $438.60
Upside: -
Jun 8, 2018
Maintains: Buy
Price Target: $41 → $42
Current: $40.96
Upside: +2.54%
Jun 8, 2018
Maintains: Neutral
Price Target: $197 → $198
Current: $203.87
Upside: -2.88%
Jun 8, 2018
Maintains: Buy
Price Target: $103 → $104
Current: $116.21
Upside: -10.51%
Jun 8, 2018
Maintains: Buy
Price Target: $74 → $76
Current: $69.40
Upside: +9.51%
Mar 8, 2018
Maintains: Buy
Price Target: $20 → $18
Current: $17.37
Upside: +3.66%